Does Wegovy help you lose belly fat — and how much?

What 'belly fat' actually means here, and why it matters for your decision

When people ask about belly fat, they usually mean one of two things: the softer fat just under the skin (subcutaneous fat), or the firmer, deeper fat that wraps around the liver, pancreas and other abdominal organs (visceral fat). Visceral fat is the type most closely linked to cardiovascular risk, insulin resistance and type 2 diabetes, so reducing it carries real health significance beyond appearance.

Wegovy works by mimicking the gut hormone GLP-1, which signals fullness to the brain, slows the rate at which the stomach empties and reduces overall calorie intake over time. You can read more about the mechanism on our overview of how Wegovy works. Because GLP-1 receptor agonists act on appetite rather than targeting a specific body region, fat loss happens across the whole body. The research, however, does show that visceral fat tends to reduce substantially alongside the overall weight drop, which is precisely what makes these medicines clinically meaningful rather than cosmetically focused, and our page on Wegovy and belly fat explores that relationship in more detail. The NHS semaglutide medicine page explains how semaglutide is used and what to expect from treatment in plain language.

So if your concern is abdominal fat specifically, the honest answer is: Wegovy is unlikely to leave your belly fat untouched while shifting weight elsewhere. But it won't target your abdomen in isolation either.

What the trial evidence actually shows about belly fat reduction

The STEP 1 trial followed nearly 2,000 adults with obesity over 68 weeks. Participants taking semaglutide 2.4mg lost an average of around 15% of their body weight compared with around 2.4% in the placebo group, a difference that held up across different starting BMIs and ages. Published in the New England Journal of Medicine, this trial also looked at waist circumference as a secondary measure: participants on semaglutide saw meaningful reductions in waist size, a reliable proxy for abdominal fat.

Separate imaging studies in the semaglutide clinical programme found that visceral adipose tissue fell by a greater proportion than total body fat in some analyses, and our dedicated page on how semaglutide affects belly fat goes through those findings in plain terms. This is consistent with what we see in weight-loss research more broadly: visceral fat, while metabolically active and therefore potentially risky, is also more metabolically responsive to an energy deficit.

It is worth being clear about what the trials cannot promise you individually. Averages mask a wide range of responses. Some people lose considerably more than 15%; others lose less. Factors including sleep, stress, activity levels and metabolic history all play a role. A prescriber can help you understand what a realistic expectation looks like for your situation, which is exactly the kind of conversation our clinical team at nume... sorry, our clinical team handles at consultation.

Why the question of whether to try Wegovy isn't just about belly fat

If you're asking whether Wegovy targets belly fat, you may be weighing up whether the medicine is worth trying for you. That's a reasonable place to start, but it's worth broadening the frame slightly.

Wegovy is licensed for adults with a BMI of 30 or above, or 27 or above if you have a qualifying weight-related condition such as high blood pressure, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds can apply for some ethnic backgrounds under UK clinical guidance. Eligibility alone doesn't decide it; your prescriber also considers your medical history, current medicines and whether the benefits outweigh any individual risks. The full picture of who the medicine is suited to is covered in more detail on our Wegovy treatment page.

Many people researching this are also thinking about cost. Private treatment prices vary across providers, and the total you pay should cover more than just the pen, it should include clinical assessment, aftercare and any ongoing monitoring. Our treatment options page sets out what's included in a full consultation at nume, with transparent pricing in one place, and if you're planning ahead on supply, you can also take a look at our Wegovy multipack option. There are no subscriptions and no hidden fees; every repeat order is reviewed by a prescriber before it goes out.

One thing our prescribers hear regularly: people feel slightly embarrassed asking about belly fat specifically, as though it's a vanity question. It isn't. If you want a straightforward answer to the question of whether Wegovy helps with belly fat, we cover it fully in its own guide. Central adiposity is a clinical risk factor, and reducing it has measurable health benefits. If that's your concern, it's a good one to raise.

Practical considerations before starting, side effects and what to expect

Wegovy's most common side effects are gastrointestinal: nausea, loose stools, constipation, indigestion and burping are all reported, particularly in the first few weeks or after a dose increase. For most people these settle within a fortnight or so. The treatment follows a gradual titration schedule, starting at 0.25mg and working up over several months, a pace designed to help your body adjust. The MHRA's Yellow Card reporting scheme exists for patients to flag any suspected side effects directly with the medicines regulator.

More serious effects to know about include severe stomach pain that may radiate to the back, which can indicate pancreatitis and warrants prompt medical attention. Gallbladder problems, allergic reactions and signs of dehydration from prolonged vomiting or diarrhoea are also reasons to seek help quickly. Your prescriber and the Patient Information Leaflet included with your treatment should be your first reference for anything unexpected.

Wegovy is not recommended during pregnancy, whilst breastfeeding or if you are trying to conceive. It is not licensed for anyone under 18. If you take an oral contraceptive pill, there are specific interactions to discuss with your prescriber (tirzepatide has a documented effect on pill absorption, and guidance for semaglutide differs) so raise this at consultation rather than assuming.

If you'd like to talk through whether Wegovy is the right fit for you, start your free consultation and a GPhC-registered prescriber will review your answers the same day.